Spyre Therapeutics (SYRE) Return on Sales Growth (1y) (2016 - 2024)
Spyre Therapeutics (SYRE) Return on Sales Growth (1y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 0.00 |
| 10 | Spyre Therapeutics | 256.29 Mn | 256.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -436.00 |
| Dec 31, 2023 | -270.00 |
| Sep 30, 2023 | -175.00 |
| Jun 30, 2023 | -280.00 |
| Mar 31, 2023 | -75.00 |
| Dec 31, 2022 | -106.00 |
| Sep 30, 2022 | -103.00 |
| Jun 30, 2022 | -35.00 |
| Mar 31, 2019 | -19.00 |
| Dec 31, 2018 | -7.00 |
| Sep 30, 2018 | -1.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 1.00 |
| Dec 31, 2017 | -1.00 |
| Sep 30, 2017 | -1.00 |
| Jun 30, 2017 | -1.00 |
| Mar 31, 2017 | -1.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | -3.00 |
| Jun 30, 2016 | -4.00 |